Clearview Diagnostics

Clearview Diagnostics is an artificial intelligence and biotechnology company developing software and offering laboratory services related to the diagnoses, treatment, and cost reduction of managing human diseases that is headquartered in Chicago, Illinois and was founded in 2012 by Dr. Christine Podilchuk and Dr. Richard Mammone.

The company's laboratory services specializes in, but is not limited to, urine toxicology, blood hormone, tissue, and genetic testing services. Clearview Diagnostics also offers services related to blood wellness testing, pain management, patient medication monitoring, primary care, psychiatry & mental health, women's health, and neuromusculoskeletal management.

Clearview Diagnostics uses their own proprietary cloud-based software for their laboratory services. Their software helps automate laboratory procedures to minimize human error, speed up returning patient results, and offer actionable diagnostic intelligence and assessment of health risks. The company also offers online and mobile portals with responsive user interfaces for medical practitioners and patients for ordering tests, viewing results, receiving alerts/updates, and tracking progress.

On June 1, 2013 Clearview Diagnostics announced raising $3 million in seed funding from undisclosed investors.